Palogic Value Management L.P. acquired a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The firm acquired 4,395 shares of the company’s stock, valued at approximately $565,000.
Other large investors have also recently bought and sold shares of the company. Frazier Financial Advisors LLC acquired a new position in Merck KGaA during the second quarter worth $25,000. Rakuten Securities Inc. acquired a new stake in shares of Merck KGaA in the second quarter worth about $27,000. Solstein Capital LLC acquired a new stake in shares of Merck KGaA in the second quarter worth about $33,000. Delos Wealth Advisors LLC bought a new stake in shares of Merck KGaA during the 2nd quarter worth about $33,000. Finally, Burk Holdings LLC bought a new stake in shares of Merck KGaA during the 2nd quarter worth about $39,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Stock Performance
Shares of OTCMKTS MKGAF opened at $164.58 on Thursday. The business’s 50-day simple moving average is $163.19 and its 200-day simple moving average is $148.83. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The firm has a market cap of $21.27 billion, a price-to-earnings ratio of 25.13 and a beta of 0.96.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
